IDEXX Laboratories Forecast, price target & analysts
IDEXX Laboratories Target price 2026 - Analyst rating & recommendation
IDEXX Laboratories Classifications & Recommendation
IDEXX Laboratories Price Target
| Target Price | $719.10 |
| Price | $518.39 |
| Potential | 38.72% |
| Number of Estimates | 17 |
| 17 Analysts have issued a price target IDEXX Laboratories 2027 . The average IDEXX Laboratories target price is $719.10. This is 38.72% higher than the current stock price. The highest price target is $845.25 63.05% , the lowest is $477.17 7.95% . | |
| A rating was issued by 22 analysts: 14 Analysts recommend IDEXX Laboratories to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the IDEXX Laboratories stock has an average upside potential 2027 of 38.72% . Most analysts recommend the IDEXX Laboratories stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
19 Analysts have issued a sales forecast IDEXX Laboratories 2026 . The average IDEXX Laboratories sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an IDEXX Laboratories EBITDA forecast 2026. The average IDEXX Laboratories EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 IDEXX Laboratories Analysts have issued a net profit forecast 2026. The average IDEXX Laboratories net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
19 Analysts have issued a IDEXX Laboratories forecast for earnings per share. The average IDEXX Laboratories EPS is
This results in the following potential growth metrics and future valuations:
IDEXX Laboratories...
Current IDEXX Laboratories Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Aug 11 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Aug 05 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Aug 05 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 27 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Apr 28 2026 |
| Citigroup |
➜
Neutral
|
Initiated | Apr 15 2026 |
| Stifel |
Buy
➜
Buy
|
Unchanged | Mar 31 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Aug 11 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Aug 05 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Aug 05 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 27 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Apr 28 2026 |
|
Initiated
Citigroup:
➜
Neutral
|
Apr 15 2026 |
|
Unchanged
Stifel:
Buy
➜
Buy
|
Mar 31 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
